These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18612507)

  • 21. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The electrocardiographic interpretation of ventricular pacing suppression algorithms in the pacemaker.
    Ząbek A; Boczar K; Nowosielska-Ząbek E; Golińska-Grzybała K; Dębski M; Ulman M; Małecka B
    J Electrocardiol; 2022; 72():1-5. PubMed ID: 35219111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.
    Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T wave oversensing and low percentage of biventricular pacing in cardiac resynchronization therapy.
    Lezcano AO; Aracama JM; Ayestaran VU; Urra FG
    Cardiol J; 2009; 16(6):580-1. PubMed ID: 19950098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
    Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
    J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1309-19. PubMed ID: 11196552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of hyperkalaemia on cardiac rhythm devices.
    Barold SS; Herweg B
    Europace; 2014 Apr; 16(4):467-76. PubMed ID: 24465006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of rate regularity and multiplicity measures to detect ventricular tachycardia in the presence of atrial fibrillation or flutter.
    Chiang CM; Jenkins JM; DiCarlo LA
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1503-8. PubMed ID: 7991421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facilitating Conversion of Implantable Cardioverter-Defibrillator Therapy to Pacing Only-Time to Adapt.
    Kramer DB; Buxton AE; Zimetbaum PJ
    JAMA Cardiol; 2019 May; 4(5):401-402. PubMed ID: 30994859
    [No Abstract]   [Full Text] [Related]  

  • 30. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II.
    Steinberg JS; Fischer A; Wang P; Schuger C; Daubert J; McNitt S; Andrews M; Brown M; Hall WJ; Zareba W; Moss AJ;
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):359-65. PubMed ID: 15828875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inappropriate shock delivery by implantable defibrillators with dual chamber pacing during nonsustained ventricular tachycardia in patients with heart block.
    Sra J; Akhtar M
    Pacing Clin Electrophysiol; 2000 Jun; 23(6):1054-6. PubMed ID: 10879396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of morphology discrimination for ventricular tachycardia diagnosis in implantable cardioverter-defibrillators.
    Theuns DA; Rivero-Ayerza M; Goedhart DM; van der Perk R; Jordaens LJ
    Heart Rhythm; 2006 Nov; 3(11):1332-8. PubMed ID: 17074640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
    Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial.
    Wilkoff BL; Kudenchuk PJ; Buxton AE; Sharma A; Cook JR; Bhandari AK; Biehl M; Tomassoni G; Leonen A; Klevan LR; Hallstrom AP;
    J Am Coll Cardiol; 2009 Mar; 53(10):872-80. PubMed ID: 19264245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
    Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
    Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A devices' game of thrones: cardiac resynchronization therapy vs. pacemaker.
    Moura-Ferreira S; Gonçalves H; Oliveira M; Primo J; Fonseca P; Ribeiro J; Santos E; Pelicano N; Martins D; Gama V
    Europace; 2017 Dec; 19(12):2042-2046. PubMed ID: 28430911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inappropriate atrial and ventricular pacing during sustained ventricular tachycardia.
    Wu M; Sharma E; Chu A
    J Cardiovasc Electrophysiol; 2020 Dec; 31(12):3351-3355. PubMed ID: 32966671
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
    Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.